Trial intelligence / Profile preview

Acetazolamide for Prevention of Acute Mountain Sickness During Rapid Ascent

NCT01418157Phase 4Completed

Sponsor
Oxford University Clinical Research Unit
Start
Aug 2011
Primary completion
Oct 2011
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of acetazolamide in acute mountain sickness (AMS), sponsored by Oxford University Clinical Research Unit. Started Aug 2011; status: completed.

02

Drugs

acetazolamide
03

Conditions

acute mountain sickness (AMS)

Beyond the preview

Go deeper on NCT01418157.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01418157.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call